🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Vaccine Response

RSV Vaccination in Immunocompromised Patients. NCT06597916Phase 21 site📍 Vienna Medical University of Vienna · Tests: Arexvy powder and suspension for injection Immunogenicity and Safety of Respiratory Syncytial Virus Vaccine in Lung Transplant Recipients NCT07895394Phase 41 site📍 Seoul Seoul National University Hospital · Tests: RSVPreF3 vaccination Using Neoantigen Peptide Vaccine/neoantigen-based DC to Treat Advanced Malignant Solid Tumors NCT05749627NA1 site📍 Nanchang The First Affiliated Hospital of Nanchang University · Tests: Neoantigen peptide vaccine, Neoantigen-based DC immune preparation A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age NCT06702449Phase 1, Phase 28 sites📍 Lenexa📍 Secaucus📍 Rochester GlaxoSmithKline · Tests: Candidate UTI vaccine low dose formulation 1, Candidate UTI vaccine low dose formulation 2, Candidate UTI vaccine mediu… A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age NCT07851246Phase 312 sites📍 Glendale📍 Tucson📍 San Diego GlaxoSmithKline · Tests: mRNA Seasonal Flu vaccine, Comparator 1, Comparator 2 Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients NCT04948619Phase 21 site📍 Charlotte Wake Forest University Health Sciences · Tests: Vaccine TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B NCT04843852Phase 11 site📍 Baltimore University of Maryland, Baltimore · Tests: Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B] BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants NCT06741072Phase 11 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Biospecimen Collection, Dulbecco''s Phosphate-Buffered Saline, Peptide Vaccine, QS21 Intranasal WSK-IM05 Vaccine Plus Tislelizumab as Neoadjuvant Therapy for HPV+ OPSCC NCT07565740Phase 11 site📍 Chengdu West China Hospital · Tests: WSK-IM05 (4×10^10 vp), WSK-IM05 (8×10^10 vp), WSK-IM05 (1.6x10^11 vp), Tislelizumab Persistence of Immune Response Six Years After One Dose of 9vHPV Vaccine Among Male and Female Students NCT07156084Phase 41 site📍 Québec Canadian Immunization Research Network · Tests: HPV nonavalent vaccine (Gardasil-9) Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination NCT04706390n/a1 site📍 Bergen University of Bergen · Tests: covid-19 vaccine Characterization of Vaccine-induced Responses Against Monkeypox (MoVIHvax) An Observational Prospective Cohort Study NCT05562323n/a3 sites📍 Badalona📍 Barcelona📍 Barcelona Fundación FLS de Lucha Contra el Sida, las Enfermedades Inf… Systems Investigation of Vaccine Responses in Aging and Frailty NCT05291676Phase 21 site📍 New Haven Yale University · Tests: Fluzone, Fluad A Study to Evaluate the Safety, Reactogenicity, and Immune Response of the GSK Vaccines Institute for Global Health (GVGH) Quadrivalent Pan-Salmonella Vaccine With and Without Alum in Healthy Young Adults NCT07663032Phase 11 site📍 Bloemfontein GlaxoSmithKline · Tests: Pan-Salmonella-with-Alum (Low dose) vaccine, Pan-Salmonella-with-Alum (Full dose) vaccine, Pan-Salmonella-without-Alum … Improving Vaccine Protection for Adults NCT07527247Phase 21 site📍 Singapore Singapore General Hospital · Tests: AS01 adjuvant (0.5 mL intramuscular), YF17D (Stamaril, Sanofi-Pasteur), Placebo (NaCl 09%, 0.5mL) VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older NCT01132859n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age NCT06806137Phase 36 sites📍 Salvaleón de Higüey📍 Constanza📍 Santo Domingo Oeste GlaxoSmithKline · Tests: Investigational varicella vaccine, Marketed varicella vaccine, MMR vaccine, Hepatitis A vaccine, PCV (pneumococcal conj… Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis NCT04588077Phase 41 site📍 Baltimore Mercy Medical Center · Tests: Heplisav-B Injectable Product, 2-dose regimen, Heplisav-B Injectable Product, 3-dose regimen Post-Vaccination Biological Collection NCT03875703n/a1 site📍 Créteil Assistance Publique - Hôpitaux de Paris The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses NCT06128915Phase 41 site📍 Buffalo State University of New York at Buffalo · Tests: vaccine Bone Marrow and Peripheral Blood Immune Responses Study NCT05616546Phase 41 site📍 Atlanta Emory University · Tests: Influenza Vaccine Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer NCT01720836Phase 1, Phase 21 site📍 Pittsburgh Olivera Finn · Tests: Vaccine + PolyICLC Reduced Vaccine Response to HZ/su in SLE NCT07636044n/a1 site📍 Seoul Seoul National University Hospital Safety and Immunogenicity of Recombinant Zoster Vaccine for Transplant Recipients NCT06262776NA1 site📍 Adelaide Central Adelaide Local Health Network Incorporated · Tests: Recombinant zoster vaccine adjuvanted (SHINGRIX) A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age NCT06855160Phase 322 sites📍 Tucson📍 Huntington Park📍 Sherman Oaks GlaxoSmithKline · Tests: Candidate varicella vaccine, Marketed varicella vaccine, MMR vaccine, Hepatitis A vaccine, PCV (pneumococcal conjugate … Vaccine Responses in Patients With B Cell Malignancies NCT05170399Phase 41 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) · Tests: AREXVY, ABRYSVO, PREVNAR 20, PNEUMOVAX 23, Heplisav -B, PREVNAR 13 Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation NCT06181656n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Pneumonia vaccine GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE NCT06620185NA1 site📍 London Imperial College London · Tests: FLUENZ, Influenza challenge virus Vaccine-induced Immunity in Immunocompromised Patients NCT06612515n/a1 site📍 Cologne University of Cologne Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients NCT02232191Phase 21 site📍 Sacramento University of California, Davis · Tests: Pneumovax-23
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy